ANIP insider trading
NasdaqGM HealthcareANI PHARMACEUTICALS INC — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About ANI PHARMACEUTICALS INC
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. It markets, sells, and distributes its products through wholesalers, retail market chains, distributors and specialty pharmacies, group purchasing organizations, specialty pharmacies, hospitals, clinics, and physicians. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
Company website: www.anipharmaceuticals.com
ANIP insider activity at a glance
FilingIQ has scored 685 insider transactions for ANIP since Mar 12, 2015. The most recent filing in our index is dated May 13, 2026.
Across the full history, 19 open-market purchases
and 245 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on ANIP insider trades is 62.3/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest ANIP Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Top insiders trading ANIP
13F funds holding ANIP
Frequently asked
- How many insider trades does FilingIQ track for ANIP?
- FilingIQ tracks 685 Form 4 insider transactions for ANIP (ANI PHARMACEUTICALS INC), covering filings from Mar 12, 2015 onwards. 45 of those were filed in the last 90 days.
- Are ANIP insiders net buyers or net sellers?
- Across the full Form 4 history for ANIP, 19 transactions (3%) were open-market purchases and 245 (36%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does ANIP insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is ANIP in?
- ANI PHARMACEUTICALS INC (ANIP) is classified in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a current market capitalisation of $1.72B.
Methodology & sources
Every ANIP insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.